fasudil has been researched along with Aortic Diseases in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noma, K | 1 |
| Goto, C | 1 |
| Nishioka, K | 1 |
| Jitsuiki, D | 1 |
| Umemura, T | 1 |
| Ueda, K | 1 |
| Kimura, M | 1 |
| Nakagawa, K | 1 |
| Oshima, T | 1 |
| Chayama, K | 1 |
| Yoshizumi, M | 1 |
| Liao, JK | 1 |
| Higashi, Y | 1 |
1 other study available for fasudil and Aortic Diseases
| Article | Year |
|---|---|
Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Adult; Aortic Diseases; Atherosclerosi | 2007 |